Skip to main content

Advertisement

Log in

Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis

  • Original Articles
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

The vasoactive intestinal peptide concentration was examined in the colonic wall and portal venous plasma of rats with chemical colitis by radioimmunoassay, and the colonic localization was determined with immunocytochemistry. Colonic acetylcholine esterase activity was also measured, and the response of vasoactive intestinal peptide to acetylcholine administration was determined. Colitis was induced by administration of dextran sulfate for three months. The chemical colitis was histologically similar to active human ulcerative colitis. We observed a significant increase of immunostained neurons and nerve fibers and a significant rise in the colonic wall vasoactive intestinal peptide content in chemical colitis rats, while plasma concentrations of the peptide did not change significantly. Colonic acetylcholine esterase activity was significantly elevated in colitis rats compared with control rats. Systemic administration of acetylcholine significantly increased the colonic and plasma vasoactive intestinal peptide concentrations in colitis rats. These findings demonstrated a positive association between colitis activity and an increase of vasoactive intestinal peptide and suggested that increased vagal tone promoted the peptide's release.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schultzberg M, Hokfelt T, Nilsson G, Terenius L, Rehfeld JF, Brown M, Elde R, Goldstein M, Said S: Distribution of peptide and catecholamine-containing neurons in the gastrointestinal tract of rat and guinea pig: Immunohistochemical studies with antisera to substance P, vasoactive intestinal peptide, enkephalins, somatostatin, gastrin/cholecystokinin, neurotensin, and dopamine b-hydroxylase. Neuroscience 5:689–744, 1980

    Google Scholar 

  2. Probert L, De Mey J, Polak JM: Ultrastructural localization of four different neuropeptides within separate populations of p-type nerves in the guinea pig colon. Gastroenterology 85:1094–1104, 1983

    Google Scholar 

  3. Ferri G-L, Adrian TE, Ghatei MA, O'Shaughnessy DJ, Probert IL, Lee YC, Buchan AMJ, Polak JM, Bloom SR: Tissue localization and relative distribution of regulatory peptides in separated layers from the human bowel. Gastroenterology 84:777–786, 1983

    Google Scholar 

  4. Kishimoto K, Koh H, Yamamoto M, Miyoshi A, Yanaihara N: Immunocytochemical study on VIP in physiological and disease conditions. Prog Gastrointest Horm VIP 4:110–124, 1981 (In Japanese)

    Google Scholar 

  5. Bryant MG, Bloom SR, Polak JM, Modlin I, Albuquerque R, Pearse AGE: Possible dual role for vasoactive intestinal peptide as gastrointestinal hormone and neurotransmitter substance. Lancet 1:991–994, 1976

    Google Scholar 

  6. Bishop AE, Polak JM, Bryant MG, Bloom SR, Hamilton S: Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease. Gastroenterology 79:853–860, 1980

    Google Scholar 

  7. Sjolund K, Schaffalitzky De Muckadell OB, Fahrenkrug J, Hakanson R, Peterson BG, Sundler F: Peptide-containing nerve fibres in the gut wall in Crohn's disease. Gut 24:724–733, 1983

    Google Scholar 

  8. O'Moran C, Bioshop AE, McGregor GP, Levi AJ, Bloom SR, Polak JM, Peter TJ: Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease. Gut 25:56–61, 1984

    Google Scholar 

  9. Koch TR, Cartney JA, Go VLW: Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel disease. Dig Dis Sci 32:369–376, 1987

    Google Scholar 

  10. Duffy LC, Zielezny MA, Riepenhoff-Talty M, Byer TE, Marshall J, Weiser MM, Graham S, Orga PL: Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease. Dig Dis Sci 34:1528–1535, 1989

    Google Scholar 

  11. Hirono I: Induction of intestinal tumors in rats by dextran sulfate sodium. J Natl Cancer Inst 66:579–583, 1981

    Google Scholar 

  12. Ohkusa T: Production of experimental ulcerative colitis in hamsters by dextran sulfate sodium and changes in intestinal microflora. Jpn J Gastroenterol 82:1327–1336, 1985 (in Japanese, abstract in English)

    Google Scholar 

  13. Pearse AGE, Polak JM: Bifunctional reagents as vapour and liquid phase fixatives for immunohistochemistry. Histochem J 7:179–186, 1975

    Google Scholar 

  14. Yanaihara N, Sakagami M, Sato H, Yamamoto K, Hashimoto T, Yanaihara C, Itoh Z, Yamaguchi K, Abe K: Immunological aspects of secretin, substance P, and VIP. Gastroenterology 72:803–806, 1977

    Google Scholar 

  15. Fonnum F: Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinesterase activities. Biochem J 115:465–472, 1969

    Google Scholar 

  16. Inflammatory disorders.In Morson and Dawson's Gastrointestinal Pathology, 3rd ed. Oxford, Blackwell Scientific Publications, 1990, p 491

    Google Scholar 

  17. Kishimoto S, Kobayashi H, Tamaru T, Kajiyama G, Miyoshi A: Further study of neuropeptidergic and endocrine pathology of experimental colitis. Biomed Res 9 (suppl): 1–26, 1988 (abstract)

    Google Scholar 

  18. Tamaru T, Kobayashi H, Kishimoto S, Kajiyama G, Miyoshi A: Colonic cancer in experimental ulcerative colitis of rats. Gastroenterology 98:A313, 1990 (abstract)

    Google Scholar 

  19. Kobayashi H, Kishimoto S, Kajiyama G, Miyoshi A: Experimental study on inflammatory bowel disease. Part 1, Endocrine profile. Jpn J Gastroenterol 86:513, 1989 (in Japanese, abstract in English)

    Google Scholar 

  20. Fahrenkrug J: VIP as a neurotransmitter in the peripheral nervous system.In Vasoactive Intestinal Peptide. SI Said, V Mutt (eds). New York, Raven Press, 1982, pp 361–372

    Google Scholar 

  21. Domschke S, Domschke W: Biological actions of vasoactive intestinal peptide in man.In Vasoactive Intestinal Peptide. SI Said, V Mutt (eds). New York, Raven Press, 1982, pp 201–209

    Google Scholar 

  22. Domschke S, Domschke W, Bloom SR, Mitznegg P, Mitchell S, Lux G, Strunz U, Demling L: Pharmacokinetics and Pharmacodynamics.In Gut Hormones. SR Bloom (ed). New York, Churchill Livingston, 1978, pp 475–478

    Google Scholar 

  23. Modlin IM, Bloom SR, Mitchell SJ: Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischemia. Experientia 34:535–536, 1978

    Google Scholar 

  24. Straus E, Keltz TN, Yalow RS: Enzymatic degradation of VIP.In Vasoactive Intestinal Peptide. SI Said, V Mutt (eds). New York, Raven Press, 1982, pp 333–339

    Google Scholar 

  25. Cutz E, Chan W, Track NS, Goth A, Said SI: Release of vasoactive intestinal polypeptide in mast cells by histamine liberators. Nature 275:661–662, 1978

    Google Scholar 

  26. O'Dorisio MS, O'Dorisio TM, Catand S, Balcerzak S: Vasoactive intestinal polypeptide as a biochemical maker for polymorphonuclear leukocytes. J Lab Clin Med 96:666–672, 1980

    Google Scholar 

  27. Okuno M, Shinomura Y, Himeno S, Kashimura M, Tarui S: Effects of cholinergic agonists on VIP release from Missner's plexus of rabbit ileum. Biomed Res 9:119–125, 1988

    Google Scholar 

  28. Iselin CE, Martin J-L, Magistretti PJ, Ferrero JD: Stimulation by nicotine of enteric inhibitory nerves and release of vasoactive intestinal peptide in the taenia of the guinea pig caecum. Eur J Pharmacol 148:179–186, 1988

    Google Scholar 

  29. Stanisz CE, Martin J-L, Magistretti PJ, Ferrero JD: Stimulation by nicotine of enteric inhibitory nerves and release of vasoactive intestinal peptide in the taenia of the guinea pig caecum. Eur J Pharmacol 148:179–186, 1988

    Google Scholar 

  30. Stanisz AM, Scicchitano R, Bienenstock J: The role of vasoactive intestinal peptide and other neuropeptides in the regulation of the immune responsein vitro andin vivo. Ann NY Acad Sci 527:478–485, 1988

    Google Scholar 

  31. Ottaway CA, Berhaester C, Chan B, Greenberg GR: Specific finding of vasoactive intestinal peptide to human circulating mononuclear cells. Can J Physiol Pharmacol 61:664–671, 1983

    Google Scholar 

  32. Bondesson L, Norolind K, Liden S, Gafvelin G, Theodorsson E, Mutt V: Dual effects of vasoactive intestinal peptide (VIP) on leukocyte migration. Acta Physiol Scand 141:477–481, 1991

    Google Scholar 

  33. Smith KA: Interleukin 2. Annu Rev Immunol 2:319–333, 1984

    Google Scholar 

  34. Payan DG, McGillis JP, Goetzl EJ: Neuroimmunology. Adv Immunol 39:299–323, 1986

    Google Scholar 

  35. Sarin SK, Malhotra V, Gupta SS, Karol A, Gaier SK, Anaid BS: Significance of eosinophil and mast cell counts in rectal mucosa in ulcerative colitis. A prospective controlled study. Dig Dis Sci 32:363–367, 1987

    Google Scholar 

  36. Fox CC, Laqenby AJ, Moore WC, Yardley J, Bayless TE, Lichenstein LM: Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 99:119–124, 1990

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kishimoto, S., Kobayashi, H., Shimizu, S. et al. Changes of colonic vasoactive intestinal peptide and cholinergic activity in rats with chemical colitis. Digest Dis Sci 37, 1729–1737 (1992). https://doi.org/10.1007/BF01299867

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01299867

Key Words

Navigation